Literature DB >> 9622071

Apoptosis and tumor angiogenesis in cervical cancer after preoperative chemotherapy.

M Ueda1, K Ueki, K Kumagai, Y Terai, Y Okamoto, M Ueki, Y Otsuki.   

Abstract

The correlation between apoptosis and tumor angiogenesis in uterine cervical cancer treated by preoperative intraarterial infusion chemotherapy (IAC) was investigated. Cervical cancer samples surgically obtained from 12 patients (stages Ib-IIIb) receiving IAC and from 10 patients (stages Ib-IIb) receiving no chemotherapy and biopsy specimens from the 12 patients before IAC were examined. The apoptotic index (AI) was determined with an in situ end-labeling assay. Intratumoral microvessel density (IMVD) and thymidine phosphorylase (dThdPase) expression were evaluated immunohistochemically using anti-CD34 and anti-dThdPase antibodies. AIs were higher in the 8 patients with complete or partial response to IAC than they were in the 4 nonchemoresponsive patients and in the 10 patients who received no chemotherapy (P < 0.01) and were inversely related to IMVDs (r = 0.724; P < 0.01). AIs and IMVDs after IAC were higher and lower than those before IAC (P < 0.01), respectively. The expression of dThdPase, which has angiogenic activity, was markedly decreased after IAC. These results suggest that the antitumor effects of IAC are closely associated with apoptotic cell death, which may be influenced in part by the extent of tumor angiogenesis inhibition.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9622071

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Thymidine phosphorylase expression in progression of cervical cancer: correlation with microvessel count, proliferating cell nuclear antigen, and apoptosis.

Authors:  R Fujiwaki; K Hata; K Iida; Y Maede; M Koike; K Miyazaki
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

2.  Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistance.

Authors:  Michal Stark; Eran E Bram; Martin Akerman; Yael Mandel-Gutfreund; Yehuda G Assaraf
Journal:  J Biol Chem       Date:  2010-11-10       Impact factor: 5.157

3.  Long-term follow-up of neoadjuvant intraarterial chemotherapy using an original four-lumen double-balloon (4L-DB) catheter for locally advanced uterine cervical cancer.

Authors:  Yoshito Terai; Masanori Kanemura; Hiroshi Sasaki; Satoshi Tsunetoh; Yoshimichi Tanaka; Yoshiki Yamashita; Kazuhiro Yamamoto; Isamu Narabayashi; Masahide Ohmichi
Journal:  Int J Clin Oncol       Date:  2009-02-20       Impact factor: 3.402

4.  Relationship of angiogenic and apoptotic activities in soft-tissue sarcoma.

Authors:  Thin Thin Win; Hasnan Jaafar; Yusri Yusuf
Journal:  South Asian J Cancer       Date:  2014-07

Review 5.  Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interference.

Authors:  Sung Hoon Choi; Jun Yong Park
Journal:  Cancer Cell Int       Date:  2017-01-03       Impact factor: 5.722

6.  Regulation of dihydropyrimidine dehydrogenase and pyrimidine nucleoside phosphorylase activities by growth factors and subsequent effects on 5-fluorouracil sensitivity in tumor cells.

Authors:  M Ueda; K Kitaura; O Kusada; Y Mochizuki; N Yamada; Y Terai; K Kumagai; K Ueki; M Ueki
Journal:  Jpn J Cancer Res       Date:  2000-11

Review 7.  PD-1/L1 inhibitor plus chemotherapy in the treatment of sarcomas.

Authors:  Zhichao Tian; Weitao Yao
Journal:  Front Immunol       Date:  2022-08-23       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.